骨修饰剂和多激酶抑制剂作为胆瘤的治疗方法:基于TriNetX的回顾性队列研究
Kamal Shaik1, Spencer Rasmussen1, Rudy Rahme2
1Department of Neurosurgery, Drexel University College of Medicine, Philadelphia, PA 19104, USA.
Clinical neurology and neurosurgery
|December 5, 2025
概括
与denozumab相比,zoledronic acid在冠状瘤患者中显示死亡率较高,但骨硬化风险较低. 多酶抑制剂对死亡率没有影响,突出显示了罕见骨癌的全身治疗结果的多样性.
科学领域:
- 在瘤学瘤学.
- 整形瘤学 整形瘤学
- 药理学 药理学是指药理学的学科.
背景情况:
- 冠状瘤是一种罕见的轴性骨恶性瘤,具有有限的全身治疗选择.
- 骨修饰剂 (BMAs) 和多酶抑制剂 (MKIs) 显示出临床前的前景.
- 关于这些针对性治疗胆瘤的真实世界的比较数据很少.
研究的目的:
- 为了比较zoledronic acid,denosumab和MKI在冠状瘤患者的实际有效性.
- 在诊断后5年评估生存和骨相关结果.
- 为了告知未来的系统性治疗策略,为心脏瘤.
主要方法:
- 使用TriNetX研究网络进行的回顾性队列研究.
- 冠状瘤患者通过列龙酸,苏马布或MKI治疗进行了分层.
- 倾向性得分匹配用于控制混因子;在5年后分析结果.
主要成果:
- 佐乐德罗尼酸与较高的5年死亡率和较低的骨硬化风险相比,与德诺苏马布相关.
- 与BMA相比,MKI在死亡率上没有显著差异.
- 在治疗组之间没有观察到病理性骨折或脊髓压缩率的显著差异.
结论:
- 在chordoma.com中,BMAs (zoledronic acid与denosumab) 之间的生存和骨结局存在显著差异.
- 目前的数据表明,MKI可能不会比BMA提供生存益处.
- 前性研究对于建立心脏瘤的最佳系统治疗方案至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:27Fractures: Bone Repair
4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K